Currently set to Index
Currently set to Follow
NCCS Starburst 250px

What Caught Our Eye: A New GOP Health Plan, Looming Uncertainty for Insurers, Sharing Genetic Cancer Risks with Children, and More

/in , , ,
What Caught Our Eye (WCOE), April 21, 2017
What Caught Our Eye is our week-in-review blog series, where we recap the cancer policy articles, studies, and stories that caught our attention.

In the Spotlight

Trumpcare is back. And worse than ever.

Via Vox.com — “House Republicans are floating a new amendment to their health care bill — one that would likely cause even more Americans to lose coverage than the last version.“Leaders of the staunchly conservative Freedom Caucus and the more moderate Tuesday Group have reportedly hashed out a proposal that would let some states ditch key Obamacare policies, such as the requirement to charge sick people the same for coverage as healthy people. States would also have the choice to opt out of the Affordable Care Act’s essential health benefit requirement.”

Affordable Care Act

“Bare Market: What Happens if Places Have No Obamacare Insurers?”

Via New York Times Well Blog — “If all the insurers start leaving [the market], consumers there will find their options dwindling, and then their subsidies will become worthless. Most would end up uninsured. The problem could affect a substantial fraction of the approximately 11 million people currently enrolled in Obamacare coverage..”

“Health Insurers Asked Trump Administration for Reassurance on Obamacare. They Didn’t Get It.”

Via Washington Post Wonkblog — “Health insurance executives seeking certainty on the future of federal funds that help lower-income Americans with their out-of-pocket health-care costs got no commitment that they would be paid next year in an hour-long meeting with Seema Verma, administrator of the Centers for Medicare and Medicaid Services (CMS), according to two insurance industry officials with knowledge of the meeting.”

“Tom Price’s big test: Keep Obamacare afloat”

Via Politico — “President Donald Trump doubles down on his repeal rhetoric, insurers are still awaiting key Obamacare funding and new disclosures highlight two lawmakers who are raking in the health care cash. But first: Tennessee is ground zero for the urgent challenge facing HHS Secretary Tom Price.”

“White House Pressures GOP Leaders on Obamacare”

Via Politico — “The White House is pressuring House GOP leaders for another showdown vote on repealing Obamacare next week so it can notch a legislative win before President Donald Trump’s first 100 days in office. But while the outlines of a possible deal are starting to come together, it’s far from clear that House Republican leaders have found the sweet spot to pass their embattled alternative health plan.”

Cancer Policy

“FDA Approves Drug for Hodgkin Lymphoma”

From the National Cancer Institute (NCI) — “On March 14, the Food and Drug Administration (FDA) approved pembrolizumab (Keytruda®) for the treatment of some patients with classical Hodgkin lymphoma (cHL). The drug is approved for the treatment of both adult and pediatric patients with refractory cHL, or patients whose disease has relapsed after three or more lines of therapy.”

Coping with Cancer

“When to Tell Daughters About a Genetic Breast Cancer Risk”

Via New York Times Well Blog — “As genetic testing has given women and men a trove of information about their health and risk for disease, it has also created a new challenge for parents and medical experts: when to share information with children who may share a genetic risk.”

“Relationships and Metastatic Breast Cancer”

https://twitter.com/cancernews247/status/855124941204635648

Via KXLY — “Dealing with metastatic breast cancer can put additional stress on any relationship. But having supportive relationships can make a big difference in your day-to-day life and emotional health.”

More From “What Caught Our Eye” »

Follow us on Twitter: @CancerAdvocacy

Take Action

Make An Impact

We are relentless in improving the quality of care and life after a cancer diagnosis. Your support makes all the difference right now.

Make a Gift »

Join CPAT

The NCCS Cancer Policy & Advocacy Team (CPAT) is a program for survivors and caregivers to learn about pressing policy issues that affect quality cancer care in order to be engaged as advocates in public policy around the needs of cancer survivors.

Share Your Story

NCCS represents the millions of Americans who share a common experience – the survivorship experience – living with, through and beyond a cancer diagnosis.

STAY CONNECTED

Together we can improve cancer care for survivors! Sign up to be the first to know about cancer policy issues and ways to take action

  • This field is for validation purposes and should be left unchanged.

National Coalition for Cancer Survivorship
8455 Colesville Road  |  Suite 930  |  Silver Spring, MD 20910
877-NCCS-YES  |  info@canceradvocacy.org
Privacy Policy  |  Terms and Conditions

Copyright © 1995-2023 by the National Coalition for Cancer Survivorship
National Coalition for Cancer Survivorship, NCCS, Cancer Survival Toolbox, and related Logos are registered in the United States as trademarks of the National Coalition for Cancer Survivorship.

ACA Update | April 14, 2017: Town Hall Headlines, Cost-Sharing Subsidies, the...ProtectOurCare 1024pxProtectOurCare 1024pxACA Update | April 21, 2017: House GOP Readies a Revised Health Care Bill